CB
CF BANKSHARES INC. (CFBK)·Q1 2024 Earnings Summary
Executive Summary
- Q1 2024 EPS declined sequentially to $0.47 (vs $0.65 in Q4 2023; $0.68 in Q1 2023) as elevated provision expense ($1.24M) and roughly $0.75M of nonrecurring items (payroll taxes and recruiting fees) weighed on results, while core earnings (PPNR $5.0M) remained solid .
- Net interest margin was relatively stable at 2.36% (down 8 bps QoQ), with pressure from fewer days and lower loan fees; management “held the line” on deposit pricing amid competitors’ ultra-high money-market rates, helping maintain cost of funds .
- Credit quality remains solid but normalizing: nonaccrual loans rose to $7.9M (0.46% of loans) and provision increased to $1.24M as reserves on an individually evaluated commercial loan were built; net recoveries were $16K in the quarter .
- Potential stock catalysts: delivery of fee-income growth in Treasury Management and Mortgage Lending, continued NIM stabilization, and improved deposit mix (core deposits +$30.8M QoQ) could support sentiment if executed .
What Went Well and What Went Wrong
-
What Went Well
- Core deposit momentum and discipline on pricing: core deposits increased $30.8M QoQ as the bank “held the line” on rates despite competitive pressure; management emphasized maintaining overall cost of funds .
- PPNR remained healthy at $5.0M, underscoring core earning power despite seasonal and one-time headwinds .
- Strategic build-out continues: three senior commercial banking leaders added across Treasury Management, Central Ohio, and Indianapolis to drive growth and fee initiatives .
-
What Went Wrong
- Earnings pressure from credit costs and nonrecurring items: provision rose to $1.24M and about $0.75M of nonrecurring expenses (higher first‑quarter payroll taxes and recruiting fees) reduced quarterly profitability .
- NIM edged lower to 2.36% (–8 bps QoQ) reflecting fewer days and lower loan fees; efficiency ratio worsened to 58.96% vs 52.75% in Q4 2023 .
- Asset quality normalization continued: nonaccrual loans increased to $7.9M (0.46% of loans) from $5.7M (0.33%) in Q4, primarily tied to a handful of loans moving to nonaccrual; allowance coverage increased to 1.06% of loans .
Financial Results
Income statement and EPS vs prior periods
Margins and ratios
Balance sheet and asset quality KPIs
Additional operating details
- Loan production and sales: New commercial loan production was $37.3M; notional loans sold were $9.0M vs $2.0M in Q4 2023 .
- Deposits mix: Core deposits +$28.5M QoQ, brokered deposits −$51.1M QoQ; ~29.8% of balances were above FDIC limits (vs 29.2% in Q4) .
Estimates comparison
- Consensus EPS and revenue estimates from S&P Global were not available for comparison at the time of this analysis; therefore, no vs-consensus columns are shown. We will update when available.
Guidance Changes
- The company did not issue formal quantitative guidance. Management provided qualitative commentary summarized below.
Earnings Call Themes & Trends
Note: A Q1 2024 earnings call transcript was not available; themes reflect management’s press release commentary and prior quarter releases.
Management Commentary
- “Our Q1 results were impacted by $1.2 million of provision expense, coupled with approximately $750 thousand of other nonrecurring items including higher payroll tax expense… and recruiting fees. PPNR was $5.0 million for the quarter reflective of solid core earnings performance.”
- “Our NIM for Q1 included some one-time impacts including fewer days along with lower loan fees… we held the line and successfully maintained our overall cost of funds.”
- “We anticipate positive growth in interest income as new loan pricing is adjusted upward, plus existing loans refinancing at higher market rates… [requiring] lower net loan growth rates and… deploying less capital.”
- “Going forward we believe our business initiatives will result in fee income growth. In particular, we see opportunities within our Treasury Management and Mortgage Lending lines of business.”
- “Credit quality remains strong… We believe our industry, CFBank included, will return to more normalized levels of loan losses going forward.”
Q&A Highlights
- No Q1 2024 earnings call transcript was available; therefore, no Q&A details to report [Search returned none; see absence of transcript in filings between Apr–Jun 2024].
Estimates Context
- Wall Street consensus estimates (S&P Global) were unavailable for CFBK at the time of this analysis, so we cannot quantify beats/misses vs consensus. We will update when S&P Global consensus can be retrieved.
Key Takeaways for Investors
- Earnings softer QoQ on credit costs and nonrecurring items, but core earnings (PPNR $5.0M) and stable NIM indicate resilient underlying profitability .
- Deposit discipline and improving mix are notable positives amid aggressive competitor pricing; core deposits rose $30.8M QoQ while brokered balances declined $51.1M .
- Asset quality is normalizing from very low loss levels; nonaccruals increased to 0.46% of loans and ACL rose to 1.06%—a prudent stance that should buffer potential losses .
- Management sees interest income growth from repricing/refinancings even with lower net loan growth—favoring return on capital and margin protection over volume .
- Fee-income initiatives (Treasury Management, Mortgage Lending) and recent senior hires are medium-term growth levers that can diversify revenues beyond spread income .
- Capital remains solid (Tier 1 leverage 10.05%, Total capital 13.50%), supporting growth and continued $0.06/share dividend .
- Near-term watch items: trajectory of NIM stabilization, pace of fee-income ramp, and resolution of newly nonaccrual loans—each a potential catalyst for multiple re-rating if executed well .
References
- Q1 2024 earnings 8‑K and Exhibit 99.1 press release, including full financials and KPI tables .
- Q4 2023 earnings 8‑K and press release for sequential comparisons .
- Q3 2023 earnings 8‑K and press release for two‑quarter trend context .
- Additional Q1 2024 press releases: three commercial leadership additions (Apr 23, 2024) and dividend declaration (Apr 8, 2024) .